ライフサイエンスコーパス: breast cancer resistance protein

1 C1 (multidrug resistant protein 1) or ABCG2 (breast cancer resistance protein).

2 sporters, multidrug resistance protein 2 and breast cancer resistance protein.

3 ABC) transporter proteins, P-glycoprotein or breast cancer resistance protein.

4 ated with enhanced expression of Pgp but not breast cancer resistance protein.

5 e membrane vesicles expressing human MRP2 or breast cancer resistance protein.

6 ate for the ATP-binding cassette transporter breast cancer resistance protein.

7 Breast cancer resistance protein 1 (Bcrp1), an efficient

8 Finally, we identified breast cancer-resistance protein 1-expressing verapamil-

9 33342 from these cell lines defined a human breast cancer-resistance protein 1-expressing, verapamil

10 so known as mitoxantrone resistance protein, breast cancer-resistance protein, ABC placenta) is a mem

11 s of compounds was found to also inhibit the breast cancer resistance protein ABCG2 but with totally

12 ional activity of P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) efflux transpor

13 multidrug resistance protein 1 (ABCC1), and breast cancer resistance protein (ABCG2) play an importa

14 The breast cancer resistance protein (ABCG2) transports chem

15 Breast cancer resistance protein (ABCG2), a transporter

16 resistance associated protein 4 (ABCC4) and breast cancer resistance protein (ABCG2), are important

17 flux transport by P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2), thereby limiti

18 tivates the ATP-binding cassette transporter breast cancer resistance protein (ABCG2).

19 PBX1 ALL, significantly higher expression of breast cancer resistance protein (ABCG2, an MTX efflux t

20 The multidrug transporter, breast cancer resistance protein, ABCG2, is up-regulated

21 cassette subfamily B, member 1 [ABCB1]) and breast cancer resistance protein (adenosine triphosphate

22 multidrug resistance-related protein 1, and breast cancer resistance protein after treatment.

23 ce protein 1 (MRP1), P-glycoprotein, and the breast cancer resistance protein are each present in a p

24 multidrug resistance-associated protein, and breast cancer resistance protein are known to transport

25 er of stem and progenitor cells known as the breast cancer resistance protein (BCRP or ABCG2) confers

26 ssette transporters P-glycoprotein (Pgp) and breast cancer resistance protein (BCRP) are 2 major gate

27 resistance-associated protein 2 (Mrp2), and breast cancer resistance protein (BCRP) expression in ra

28 -response elements and significantly induced breast cancer resistance protein (BCRP) gene transcripti

29 ation of pioglitazone, whereas inhibition of breast cancer resistance protein (BCRP) has little effec

30 ole for the ATP-binding cassette transporter breast cancer resistance protein (BCRP) in MTX resistanc

31 Breast cancer resistance protein (BCRP) is a newly ident

32 Breast cancer resistance protein (BCRP) is a novel membe

33 The breast cancer resistance protein (BCRP) is an ATP-bindin

34 Breast cancer resistance protein (BCRP) is expressed in

35 Breast cancer resistance protein (BCRP) is most abundant

36 Breast cancer resistance protein (BCRP) plays a signific

37 ransporters (e.g., P-glycoprotein (P-gp) and breast cancer resistance protein (Bcrp)) at the BBB limi

38 rostate cancer, are defined by expression of breast cancer resistance protein (BCRP), a marker of plu

39 strated that T98G and HCT8 cells express the breast cancer resistance protein (BCRP), a recently clon

40 ance-associated protein-2 (Mrp2), Abcc2; and breast cancer resistance protein (Bcrp), Abcg2].

41 These cells overexpress the breast cancer resistance protein (BCRP), and resistance

42 ncluding multidrug resistance protein (MRP), breast cancer resistance protein (BCRP), and/or Pgp.

43 ransporters, e.g., P-glycoprotein (P-gp) and breast cancer resistance protein (BCRP), at the blood-br

44 The new transporter was termed the breast cancer resistance protein (BCRP), because of its

45 g-resistance associated protein 4 (MRP4) and breast cancer resistance protein (BCRP), located on endo

46 The multidrug transporters breast cancer resistance protein (BCRP), multidrug-resis

47 The gene encoding a novel transporter, the breast cancer resistance protein (BCRP), was recently fo

48 doxorubicin and mitoxantrone are effluxed by breast cancer resistance protein (BCRP), we assessed whe

49 resistance-associated protein 1 (MRP1), and breast cancer resistance protein (BCRP), which may serve

50 However, cells transfected with the breast cancer resistance protein (BCRP)-the ABC transpor

51 transporters P-glycoprotein (P-gp/MDR1) and breast cancer resistance protein (BCRP).

52 tance protein (LRP), and, more recently, the breast cancer resistance protein (BCRP).

53 tte superfamily of transporters that we term breast cancer resistance protein (BCRP).

54 Breast cancer resistance protein (BCRP)/MXR/ABCG2 is a n

55 ance-associated protein 1 (MRP1, ABCC1), and breast cancer resistance protein (BCRP, ABCG2) are the t

56 The breast cancer resistance protein (BCRP, ABCG2) belongs t

57 function and substrate specificity of human breast cancer resistance protein (BCRP, ABCG2) in the ab

58 Presence of the breast cancer resistance protein (BCRP, ABCG2) was confi

59 stituents showed moderate inhibition against breast cancer resistance protein (BCRP, ABCG2).

60 otein (P-gp, official gene symbol ABCB1) and breast cancer resistance protein (BCRP, official gene sy

61 tandem mass spectrometry (LC-MS/MS) mediated breast cancer resistance protein (BCRP/ABCG2) and bile s

62 The human breast cancer resistance protein (BCRP/ABCG2) confers mu

63 We investigated the role of the breast cancer resistance protein (BCRP/ABCG2) in drug re

64 Breast cancer resistance protein (BCRP/ABCG2) is a molec

65 The Breast Cancer Resistance Protein (BCRP/ABCG2) is one mem

66 The human breast cancer resistance protein (BCRP/ABCG2) mediates e

67 Breast cancer resistance protein (BCRP/ABCG2) plays an i

68 Breast cancer resistance protein (BCRP/ABCG2), an ATP-bi

69 in the transport process, in particular for breast cancer resistance protein (BCRP/ABCG2), there is

70 ase inhibitor, is effluxed from cells by the breast cancer resistance protein (BCRP/ABCG2), yet publi

71 transporters P-glycoprotein (Pgp/MDR-1) and breast cancer resistance protein (BCRP/ABCG2).

72 ance-associated proteins (MRP1-MRP6), or the breast cancer resistance protein (BCRP/MXR), the (67)Ga-

73 The breast cancer resistance protein (BCRP; ABCG2) is an ATP

74 port by P-glycoprotein (P-gp; ABCB1) and the breast cancer resistance protein (BCRP; ABCG2) was teste

75 the ATP-binding cassette (ABC) transporters: breast cancer resistance protein (BCRP; ABCG2), multidru

76 imarily been attributed to the inhibition of breast cancer resistance protein (BCRP; ABCG2).

77 several membrane transporters, in particular breast-cancer resistance protein (BCRP), to exit the BBB

78 triphosphate-binding cassette protein ABCG2 (breast cancer resistance protein [BCRP], mitoxantrone re

79 nvestigate transcriptional activation of the breast cancer resistance protein gene (BCRP/ABCG2), we e

80 d BAALC, ERG and MN1 genes and expression of breast cancer resistance protein have been shown to conf

81 such as lung-resistance protein, bcl-2, and breast cancer-resistance protein, have been described in

82 tinib with the multidrug efflux transporters breast cancer resistance protein (humans, ABCG2; rodents

83 ltidrug resistance-associated protein 1, and breast cancer resistance protein (i.e., ABCG2) consisten

84 brevianamide F analogues possess interesting breast cancer resistance protein inhibitory activity.

85 dihydroxychalcone (2',5'-DHC) to induce both breast cancer resistance protein-mediated export of glut

86 tified in small cell lung cancer followed by breast cancer resistance protein (mitoxantrone resistanc

87 Unlike ABCG2 (breast cancer resistance protein, mitoxantrone-resistant

88 otein)- and ABC subfamily G member 2 (ABCG2; breast cancer resistance protein/mitoxantrone resistance

89 1, multidrug resistance-related protein, and breast cancer resistance protein occurred after treatmen

90 t express the ABCG2 transporter (also called breast cancer resistance protein, or BCRP).

91 ated protein 1, lung resistance protein, and breast cancer resistance protein, were comparable in the